Use of 18F-FDG PET/CT in Second Primary Cancer / 핵의학분자영상
Nuclear Medicine and Molecular Imaging
;
: 185-193, 2007.
Article
in English
| WPRIM
| ID: wpr-189512
ABSTRACT
This review focuses on the use of 18F-FDG PET/CT to evaluate second primary cancers. The emergence of a second primary cancer is an important prognostic factor in cancer patients. The early detection of a second primary cancer and the appropriate treatment are essential for reducing the morbidity and mortality associated with these tumors. Integrated 18F-FDG PET/CT, which can provide both the metabolic and anatomic information of a cancer, has been shown to have a better accuracy in oncology than either CT or conventional PET. The whole body coverage and high sensitivity of 18F-FDG PET/CT along with its ability to provide both metabolic and anatomic information of a cancer make it suitable for evaluating a second primary cancer in oncology. Whole body 18F-FDG PET/CT is useful for screening second primary cancers with a high sensitivity and good positive predictive value. In order to rule out the presence of a second primary cancer or an unexpected metastasis, further diagnostic work-up is essential when abnormal findings indicative of a second primary cancer are found on the PET/CT images. PET/CT is better in detecting a second primary tumor than conventional PET.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Mass Screening
/
Mortality
/
Neoplasms, Second Primary
/
Fluorodeoxyglucose F18
/
Positron Emission Tomography Computed Tomography
/
Neoplasm Metastasis
Type of study:
Prognostic study
/
Screening study
Limits:
Humans
Language:
English
Journal:
Nuclear Medicine and Molecular Imaging
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS